Raffles Medical Faces Earnings Hit From Insurance Business' Losses -- Market Talk

Dow Jones

2024/12/05

0634 GMT - Raffles Medical faces earnings hit from its insurance business' losses, RHB Research's Shekhar Jaiswal says in a research report. At its 1H results briefing, the company said that if the insurance business continues to have high loss ratios, the business could be lossmaking for 2-3 years, the analyst notes. Higher operating costs for Singapore healthcare providers and fewer foreign patients than before the pandemic pose earnings headwinds for the medical services provider, the analyst adds. RHB lowers its 2024, 2025, and 2026 earnings estimates for Raffles Medical by 12%, 12%, and 7%, respectively. It trims the stock's target price to S$0.90 from S$1.00 and maintains a neutral rating. Shares are unchanged at S$0.885. (ronnie.harui@wsj.com)

(END) Dow Jones Newswires

December 05, 2024 01:34 ET (06:34 GMT)

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2489100122"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2489100122\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2489100122?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-05 14:34","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2489100122","market":"nz","top_or_hot":-1,"title":"Raffles Medical Faces Earnings Hit From Insurance Business' Losses -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0634 GMT - Raffles Medical faces earnings hit from its insurance business' losses, RHB Research's Shekhar Jaiswal says in a research report. At its 1H results briefing, the company said that if the insurance business continues to have high loss ratios, the business could be lossmaking for 2-3 years, the analyst notes. Higher operating costs for Singapore healthcare providers and fewer foreign patients than before the pandemic pose earnings headwinds for the medical services provider, the analyst adds. RHB lowers its 2024, 2025, and 2026 earnings estimates for Raffles Medical by 12%, 12%, and 7%, respectively. It trims the stock's target price to S$0.90 from S$1.00 and maintains a neutral rating. Shares are unchanged at S$0.885. (ronnie.harui@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 05, 2024 01:34 ET (06:34 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Raffles Medical Faces Earnings Hit From Insurance Business' Losses -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRaffles Medical Faces Earnings Hit From Insurance Business' Losses -- Market Talk\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2024-12-05 14:34</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0634 GMT - Raffles Medical faces earnings hit from its insurance business' losses, RHB Research's Shekhar Jaiswal says in a research report. At its 1H results briefing, the company said that if the insurance business continues to have high loss ratios, the business could be lossmaking for 2-3 years, the analyst notes. Higher operating costs for Singapore healthcare providers and fewer foreign patients than before the pandemic pose earnings headwinds for the medical services provider, the analyst adds. RHB lowers its 2024, 2025, and 2026 earnings estimates for Raffles Medical by 12%, 12%, and 7%, respectively. It trims the stock's target price to S$0.90 from S$1.00 and maintains a neutral rating. Shares are unchanged at S$0.885. (ronnie.harui@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 05, 2024 01:34 ET (06:34 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BSL.SI","symbol_name":"莱佛士医疗","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2489100122","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2489100122","pubTimestamp":1733380440,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0634 GMT - Raffles Medical faces earnings hit from its insurance business' losses, RHB Research's Shekhar Jaiswal says in a research report. At its 1H results briefing, the company said that if the insurance business continues to have high loss ratios, the business could be lossmaking for 2-3 years, the analyst notes. Higher operating costs for Singapore healthcare providers and fewer foreign patients than before the pandemic pose earnings headwinds for the medical services provider, the analyst adds. RHB lowers its 2024, 2025, and 2026 earnings estimates for Raffles Medical by 12%, 12%, and 7%, respectively. It trims the stock's target price to S$0.90 from S$1.00 and maintains a neutral rating. Shares are unchanged at S$0.885. ","collect":0,"end_time":0,"defaultTopTitle":"","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"BSL.SI":"莱佛士医疗"},"translate_title":"莱佛士医疗面临保险业务亏损的盈利打击——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BSL.SI":1},"content_text":"0634 GMT - Raffles Medical faces earnings hit from its insurance business' losses, RHB Research's Shekhar Jaiswal says in a research report. At its 1H results briefing, the company said that if the insurance business continues to have high loss ratios, the business could be lossmaking for 2-3 years, the analyst notes. Higher operating costs for Singapore healthcare providers and fewer foreign patients than before the pandemic pose earnings headwinds for the medical services provider, the analyst adds. RHB lowers its 2024, 2025, and 2026 earnings estimates for Raffles Medical by 12%, 12%, and 7%, respectively. It trims the stock's target price to S$0.90 from S$1.00 and maintains a neutral rating. Shares are unchanged at S$0.885. (ronnie.harui@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 05, 2024 01:34 ET (06:34 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}